Journal of Addiction Medicine

Article	Citations
A Naturalistic Study of Individuals Involved in the Justice System Who Experienced Both Formulations of Extended-release Buprenorphine	92
Methamphetamine Use in Psychiatric Emergency Services and Among Asian American and Pacific Islander Populations	67
Oral Health Risks of Transmucosal Buprenorphine: Commentary on Tuan et al. and Zheng et al.	67
Characteristics of Ongoing Clinical Trials for Cocaine Use Disorder Registered on Global Clinical Trial Databases	55
Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women’s Prison Facility, 2016–2019	55
Generative Artificial Intelligence Tools in Medicine Will Amplify Stigmatizing Language	52
Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations	42
GLP-1 RA Medication Associations With Hazardous Alcohol Drinking Reductions in Patients With Overweight or Obesity: A Prospective Observational Study	41
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial	38
Implantable Cardioverter Defibrillator Placement to Permit Ongoing Methadone Treatment Despite QT Prolongation and Torsades de Pointes: A Case Report	38
Synthetic Cathinone–Induced Myocarditis and Psychosis: A Case Report	38
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder	35
Managing Benzodiazepine Withdrawal—The Emperor’s New Clothes	34
Treatment of Kratom Use Disorder With Methadone in an Opioid Treatment Program	32
Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals	30
A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-associated Liver Disease	29
The Pharmacological Management of Ketamine Use Disorder: A Systematic Review	26
Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study	25
Perinatal Substance Use-Related Content at Major Addiction Scientific Conferences: An Analysis of Oral Presentation Sessions	24
Complicating Factors Surrounding Concurrent Use of Kratom and a Novel 7-hydroxymitragynine Product Among a Participant Enrolled in a Kratom Clinical Trial	23
Adolescent Tobacco/Nicotine Use and the Potential Role of Contingency Management-based Interventions	23
Provider Perceptions Toward Extended-Release Buprenorphine for Treatment of Opioid Use Disorder	23
Associations between Patient Experience and Addiction Treatment Facility Services: Results of the Addiction Treatment Locator, Assessment, and Standards Surveys	21
Clinical and Demographic Characteristics of Hospitalized Patients With Xylazine-related Wounds	21
Identifying Areas to Improve Care and Support Parent-Child Relationships From the Perspective of Pregnant and Parenting People in Recovery	20

Outcomes in Subsequent Pregnancies of Individuals With Opioid Use Disorder Treated in Multidisciplinary Clinic in Prior Pregnancy	20
Approaches for Managing Benzodiazepine Dependence Arising From Use of the Adulterated Opioid Supply: A Delphi Technique	19
Stigmatizing Language in Substance Use-related International Classification of Diseases Codes	18
Low-dose Buprenorphine Initiation in Pregnancy: A Systematic Review	18
Subcutaneous Extended-release Buprenorphine Depot Misdiagnosed as an Abscess Resulting in Incision and Drainage and Disruption of Opioid Use Disorder Treatment	18
Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US States	18
Testing and Case Rates of Gonorrhea, Chlamydia, Syphilis, and HIV among People with Substance Use Disorders in the Veterans Health Administration	17
Rating the Quality and Consistency of Local Opioid Settlement Expenditure Data	17
Use of Cannabinoids by People Who Consume Kratom in the United States	16
A Peer Recovery Coach Intervention for Hospitalized Patients with Opioid Use Disorder: A Pilot Randomized Controlled Trial	16
Dosing and Safety of Methadone Initiation in the Setting of Fentanyl: A Systematic Review	16
High Primary COVID-19 Vaccine Series Completion by People Who Inject Drugs When Colocating Services at a Syringe Services Van	16
Gains in Employment Status Are Associated With Lower Methamphetamine Use Frequency at Outpatient Specialty Treatment Discharge	16
Trauma Prevalence and Its Association With Health-related Quality of Life in Pregnant Persons With Opioid Use Disorder	16
Assessing Childhood Maltreatment Exposure in Patients Without and With a Diagnosis of Substance Use Disorder	16
Feasibility of Emergency Department–based Fentanyl Test Strip Distribution	15
Individuals Dispensed Buprenorphine in the United States Before and After Federal Policy Changes Aimed at Increasing Access	15
Xylazine Use Among People Who Inject Drugs, Philadelphia 2022	15
Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19	15
Adapting Contingency Management for Hospitalized Patients with Stimulant Use Disorder	15
Fentanyl Test Strips for Harm Reduction: A Scoping Review	13
Online Narcotics Anonymous: An Option for Addressing Methamphetamine Use Disorder	12
Public Xylazine Awareness and Support for Policies and Initiatives to Address the Xylazine Threat Among US Adults	12
Climate Change and the Opioid Epidemic	12
Trends in Buprenorphine and Methadone Initiation for Opioid Use Disorder Among Patients Using Fentanyl: A Mixed-methods Analysis From an Inpatient Addiction Consult Service	12
Opioid Settlements: The Role for Addiction Medicine in Guiding Effective Spending	12
Current State of Perioperative Buprenorphine Management—A National Provider Survey	12
A Hospital-based Managed Alcohol Program in a Canadian Setting	12
The Association Between Perceived Injustice and Opioid Craving in Patients With Chronic Pain: The Mediating Role of Daily Pain Intensity, Negative Affect, and Catastrophizing	12
Systematic Review of Obstetric and Child Outcomes of Prenatal Exposure to Inhalants in the Context of a Use Disorder	12
Integrative Analysis of Proteome-wide Association Studies and Functional Enrichment Analysis to Identify Genes and Chemicals Associated with Alcohol Dependence	12
Medical Detoxification for Nonopioid Substances Is Associated With Lower Likelihood of Subsequent Linkage to Substance Use Disorder Treatment	11
Estimating the Prevalence of Using Suspected Counterfeit Medications in the General Population	11
The Effect of Dehydroepiandrosterone Administration during Rehabilitation on White Matter Integrity Among Individuals With Polysubstance Use Disorder	11
Response to: “Prevalence of Kratom Use Disorder among Kratom Consumers”	11
Exploring Family Planning Perspectives Among Men Receiving Medications for Opioid Use Disorder: Implications for Service Development	11
Letter in Reply	11
Xylazine Test Strip Use Among People Who Use Drugs in New York State	10
Evidence of Designer Benzodiazepine Use in Routine Healthcare Urine Drug Specimens	10
48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method	10
Retention and Overdose Risk among Patients Receiving Substance Use Disorder Treatment, Mental Health Care and Peer Recovery Support: A Longitudinal Analysis	10
Discordance Between Self-reported and Biologically Tested Exposure to Fentanyl Among People at Risk of Opioid Overdose	10
ASAM/AAAP Clinical Practice Guideline (CPG) for Stimulant Use Disorder (StUD) Management: Commentary on Research Priorities	10
Integration of Substance Use Disorder Services in Veterans Affairs Primary Care Clinics Serving Homeless Women	10
Too Many Pills, Too Little Attention: Emphasizing Psychotropic Polypharmacy in the Overdose Conversation	10
Insurance-related Risk Factors for Leaving Against Medical Advice after Opioid Overdose: A Cross-sectional Study Using Electronic Health Records	10
The Use of Pattern Recognition to Augment Traditional Monitoring in the Prevention of Opioid Overdose Harm	10
The Difficulties in Finding the Relevant Associations Between Internet Gaming Disorder (IGD) and the Incidence of Suicide-Related Ideation and Behaviors in College Students	10
Evidence of “Repeated Admission Bias” Among Those Who Use Injection Drugs Across 2 Decades of US Treatment Admissions: 2000–2020	10
Investigating Healthcare Provider Bias Toward Patients Who Use Drugs Using a Survey-based Implicit Association Test: Pilot Study	10

Clinical Presentations and Treatment of Phenibut Toxicity and Withdrawal: A Systematic Literature Review	10
The Shifting Landscape of a Fentanyl Adulterant: Moving From Xylazine to Medetomidine	9
Response to "Two Clinical Insights on Methamphetamine Withdrawal at a Safety-net Hospital"	9
Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial	9
N-acetylcysteine Efficacy on Cocaine Base Paste Use Disorder: A Randomized Double-blind Placebo-controlled Clinical Trial	9
Aripiprazole Is Not Effective for Abstinence or Decreased Use in Alcohol and Stimulant Use Disorders in Patients Without Psychiatric Comorbidities: A Systematic Review	9
Concerns for Discharge of Persons Who Inject Drugs Home With Central Venous Catheters: A Letter to the Editor	9
Longitudinal Patterns of Dental Health Care Utilization 18 Months Before and 36 Months After Initiation of Index Medications for Opioid Use Disorder	9
Reply to: “Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine”	9
Barriers and Facilitators to Accessing Opioid Agonist Therapy for Street-involved Adolescents and Young Adults in Vancouver	9
Three-year Retention Rates With Office-based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice	9
Kratom Use Among Pregnant and Lactating Individuals With Substance Use Disorder	9
Addiction Services for Veterans: Opportunities in Acute Care	9
Wound Care Capacity of the Addiction Workforce in the Setting of Xylazine	9
The Use of a Single Dose of Phenobarbital for Inpatient Management of Benzodiazepine Withdrawal: A Case Report	9
Z-Drug Use and Benzodiazepine Use and Misuse Among LGB Populations: The Role of Psychological Distress	9
Increasing Initiation of Medications for Opioid Use Disorder Through Recovery Coaches: The Role of Implementation Setting	9
Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, Australia	9
Simultaneous Management of Alcohol Use Disorder and Liver Disease: A Systematic Review and Meta-analysis	9
Co-use of Methamphetamine Is Associated With Lower Rates of Linkage to Outpatient Treatment for Hospitalized Patients Who Initiate Buprenorphine	9
Perceptions of Overdose Response Hotlines and Phone Application Services Among Women and Gender-diverse Individuals Who Use Drugs in Canada: A Qualitative Study	9
A Scoping Review of Youth Overdose Prevention Interventions	9
Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use Disorder	9
Missed Opportunities: Substance Use Hotline Operator Uncertainty of State Buprenorphine Prescribing via Telemedicine	9
Artificial Intelligence and Stigma in Addiction Research: Insights From the HEALing Communities Study Coalition Meetings	8
Direct Induction of Buprenorphine Extended-Release: A Case Report	8
Validating the Waterpipe Addiction, Craving, and Anticipation Scale: An Exploratory Factor Analysis	8
Prevalence of Kratom Use Disorder Among Kratom Consumers	8
Cannabis and Cannabinoids for Treating Pain: What Are the Data?	8
Implementation of Specialty Tobacco Use Disorder Services in a Community Health Setting: Support for Enhanced Prescription Practices	8
Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study	8
Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation	8
Testing the Efficacy of an Adaptive Approach to Delivering Psychosocial Interventions in Office-based Buprenorphine Treatment	8
Identifying Factors Associated With Intentional and Unintentional Fentanyl Use Among People Who Use Drugs in New York City	8
Anhedonia and Substance Use Disorders by Type, Severity, and With Mental Health Disorders	8
Readmissions Among Patients With Surgically Managed Drug Use Associated-Infective Endocarditis Before and After the Implementation of an Addiction Consult Team: A Retrospective, Observational Analysis	8
Opioid Use Disorder Screening Practices in US Jails	8
Using Machine Learning to Predict Treatment Adherence in Patients on Medication for Opioid Use Disorder	8
Examining Racial/Ethnic and Income Disparities on Tobacco Product Use Among US Adults Within Wave 5 of the PATH Study	8
48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine	8
Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders: A Propensity-score Matching Cohort Study	8
Heterogeneity in Prescription Opioid Misuse Motives by Age in Adolescents and Young Adults in the United States	8
Response to: “Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial”	8
Satisfaction With Opioid Agonist Treatment: The Compelling Need for Multidimensional, Patient-centered, Patient-reported Experience Measures	8
Medication Initiation, Patient-directed Discharges, and Hospital Readmissions Before and After Implementing Guidelines for Opioid Withdrawal Management	7
Challenges of Drug Testing in Addiction Treatment	7
The Impact of Frequency of Cannabis Use on Hypertensive Disorders During Pregnancy	7
Response to the Federation of State Physician Health Program's Commentary	7
Regular Kratom (Mitragyna speciosa Korth.) Use and Its Association With Endoplasmic Reticulum Stress Response	7
Community-based Care Coordination and Treatment Retention in Opioid Use Disorder	7
Medications for Alcohol Use Disorder Among Birthing People With an Alcohol-related Diagnosis	7
Development and Validation of a High-sensitivity Rapid Xylazine Dipstick for Clinical Urine Testing	7
Disruption of Opioid Treatment Program Services Due to an Extreme Weather Event: An Example of Climate Change Effects on the Health of Persons Who Use Drugs	7
Supervised Disulfiram Should Be Considered First-line Treatment for Alcohol Use Disorder	7
Predictors of the Rate of Illicit Fentanyl Metabolism in a Cohort of Pregnant Individuals	7
“Just Be There”: Desired Partner Behaviors Among Pregnant People Living With Opioid Use Disorder, a Qualitative Study	7
A Critical Appraisal on the Alleged Carcinogenic Potential of Sublingual Buprenorphine	7
Patterns of Substance Use During Early Pregnancy and Associations With Behavioral Health Characteristics	7
Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment	7
False-Positive Phosphatidylethanol Results Due to Blood Transfusion and Implications in the Process of Liver Transplantation Selection	7
Response to Martins et al.	7
Health Care Service Presence, Social Vulnerability, and Opioid Overdose Rate Acceleration: A United States, County-level Analysis, 2020–2022	7
Identifying Barriers to Buprenorphine Treatment for Patients with Opioid Use Disorder Among Anesthesiologists and Pain Practitioners: A Survey Study	7
Emergency Department Presentations Related to the Abuse of Illicit and Prescription Opioids Through a European Sentinel-centres–Based Registry	7
Injection Drug Use and Healthcare Utilization in Patients Newly Diagnosed With HIV	7
Feasibility of a Brief Intervention to Decrease Harmful Alcohol Use Among Methadone Maintenance Treatment Clients in Shanghai: A Randomized Controlled Trial	7
Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured Fentanyl	7
The Impact of High-Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review	6
Opioid Use Disorder Among the Economically Disadvantaged in the Rural South	6
Expert Views on State Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder: A Qualitative Analysis of an Online Modified Delphi Process	6
Outpatient Direct Initiation of Injectable Buprenorphine in a Harm Reduction Agency and Primary Care Clinic: A Retrospective Case Series	6
Parosmia Is Positively Associated With Problematic Drinking, as Is Phantosmia With Depressive Symptoms	6
Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy	6
Feasibility of an Inpatient Split-Dose Rapid Methadone Induction Protocol for Pregnant Individuals	6
Gabapentin Use During Pregnancy and Lactation With and Without Concurrent Opioid Exposure: Considerations and Future Directions	6
The American Society of Addiction Medicine Clinical Practice Guideline Development Methodology	6
The Concept of Treatment-Refractory Addiction: Implications for Addiction Treatment Systems and Research	6
Participant Experiences of a Quit Smoking Attempt Through Either Nicotine Replacement Therapy (NRT) Methods or the Use of an E-cigarette	6
A Brief Screening and Assessment Tool for Opioid Use in Adults: Results from a Validation Study of the Tobacco, Alcohol, Prescription Medication, and Other Substances Tool	6
Predictors of Treatment Completion in an Inpatient Substance Use Treatment Service in India	6

Quetiapine: A Novel Additive to the Illicit Heroin Supply in Los Angeles	6
Use of Practices to Reduce of Sudden Unexpected Infant Death Among Caregivers of Opioid Exposed Newborns	6
Changes in Rates of Hospitalizations due to Cannabis Harms in Ontario, Canada Before the Legalization of Nonmedical Cannabis: Retrospective Population-level Study Between 2003 and 2017	6
Disparities in Buprenorphine Administration for Opioid Use Disorder in the Emergency Department	6
Effectiveness and Safety of Varenicline for Smoking Cessation: An Overview and Meta-analysis	6
Response to: “Clinician Perspectives on Barriers and Facilitators to Providing Medications for Opioid Use Disorder for Adolescents”	6
Xylazine Exposure and Association With Early Physiological and Withdrawal Symptoms in People With Opioid Use Disorder	6
A Critique of Phenobarbital Tapers With Buprenorphine or Methadone Initiations	6
Does Labetalol Trigger False Positive Drug Testing Results?	6
The First 100 Days: The Trump Administration and Changes to Addiction Policy	6
Naloxone Prescribing and Naloxone Administration in Response to Overdose Events Among Women With Opioid Use Disorder During Pregnancy and Postpartum Period – MAT-LINK, Seven Clinical Sites, 2014–2021	6
Safety and Efficacy of Rapid Methadone Titration for Opioid Use Disorder in an Inpatient Setting: A Retrospective Cohort Study	6
Predictive Models to Assess Risk of Persistent Opioid Use, Opioid Use Disorder, and Overdose	6
Ibogaine for Opioid Use Disorder: An Unrecognized Risk	6
A Retrospective Cohort Study of Oral Antimicrobial Therapy Offers in Hospitalized People Who Inject Drugs Who Elect for Self-directed Discharge	6
Explaining Racial-ethnic Disparities in the Receipt of Medication for Opioid Use Disorder during Pregnancy	5
Self-reported Xylazine Experiences: A Mixed-methods Study of Reddit Subscribers	5
Universal Postpartum Naloxone Provision: A Harm Reduction Quality Improvement Project	5
Xylazine-associated Wounds: Clinical Experience From a Low-barrier Wound Care Clinic in Philadelphia	5
Risk of Cannabis Use Disorder in Chronic Pain: Longitudinal Links to Pain Outcomes	5
Naloxone Use During Pregnancy—Data From 26 US Jurisdictions, 2019–2020	5
Response to: Buprenorphine Initiation, Patient Autonomy, and Informed Consent	5
The Prognostic Role of DSM-5 Alcohol Use Disorder Severity and Age of Onset in Treatment Outcome Among Adults Aged 60+	5
Privacy and Digital Health: Causes for Concern and a Way Forward	5
Exploring Preferences for Communication and Care Among Hospitalized Patients With Opioid Use Disorder: A Qualitative Descriptive Study	5
Reductions in World Health Organization Risk Drinking Level Are Associated With Reductions in Alcohol Use Disorder Diagnosis and Criteria: Evidence From an Alcohol Pharmacotherapy Trial	5
Prescribing Psychostimulants for the Treatment of Stimulant Use Disorder: Navigating the Federal Legal Landscape	5
Community Pharmacists’ Knowledge and Perceptions of Buprenorphine for Patients with Opioid Use Disorder	5
Circumstances Around Cigarette Use after Enforced Abstinence From Smoking in an American Prison	5
Opioid Agonist Therapy for Fentanyl-Related Opioid Use Disorder: A Systematic Review	5
Racial Disparities in Urine Toxicology Screening Among Pregnant People Admitted to Labor and Delivery	5
An Integrated Care Model for Pregnant and Postpartum Individuals Receiving Medication for Opioid Use Disorder	5
2024 ASAM Annual Conference Poster Abstracts	5
Microdose Induction of Buprenorphine in a Patient Using Tianeptine	5
Privacy, Care-seeking, and Stigma: A Qualitative Investigation of Patient Perspectives on Sharing Substance Use Disorder Treatment Records	5
Prevalence and Correlates of Past-year Kratom Use Among US Adults: Findings From the 2021–2023 National Survey on Drug Use and Health	5
“The Sky Didn’t Fall”: Patient and Clinician Experiences With Increased Buprenorphine Prescription Lengths During Pandemic-related Telehealth Expansion	5
Precipitated Opioid Withdrawal Treated With Ketamine in a Hospitalized Patient: A Case Report	5
Predictors of Risky Sexual Behaviors Among Female Adolescents and Young Adults Seeking Withdrawal Management Treatment: A Lifestyle-routine Activities Theory Approach	5
Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative	5
Outpatient Rapid Titration of Slow Release Oral Morphine for the Treatment of Opioid Use Disorder in a Canadian Setting: A Case Series	5